[Nfbmo] ALERT!--Senate Passes Accessible Rx Label Bill!

[Gary Wunder]

Thanks Gail. This is a good deal. I'll pass it along.
 
 

  _____  

From: Gail Bryant [mailto:gbryant at socket.net] 
Sent: Friday, May 25, 2012 10:04 AM
To: gwunder at earthlink.net
Subject: FW: ALERT!--Senate Passes Accessible Rx Label Bill!



FYI Gary.

 

Gail Bryant

Columbia Braille Teaching Services L.L.C.

1212 London Drive

Columbia, MO 65203-2012

Phone: (573)817-5993

Cell: (573)268-4962

 <mailto:gbryant at socket.net> gbryant at socket.net

 

From: AFB DirectConnect (AFB-DC) [mailto:MRichert at afb.net] 
Sent: Friday, May 25, 2012 9:00 AM
To: AFB Subscriber
Subject: ALERT!--Senate Passes Accessible Rx Label Bill!

 

				

Image removed by sender. AFB DirectConnect Letterhead


    

	

ALERT!
Senate Passes Accessible Drug Label Bill!


For further information, contact: 

Mark Richert, Esq.
Director, Public Policy, AFB
(202) 469-6833
MRichert at afb.net 

Yesterday, by a vote of 96 to 1, the U.S. Senate passed a massive package of
policy updates known as the Food and Drug Administration Safety and
Innovation Act. Read more about the legislation at:

http://www.help.senate.gov/hearings/hearing/?id=c042aa0f-5056-9502-5d26-7103
b0fba398 

The Senate-passed version of this bill includes provisions that would
establish national best practices for retail and other pharmacies to use in
providing accessible prescription drug labeling to their customers with
vision loss. Once these best practices are promulgated, a Government
Accountability Office (GAO) study will assess the extent to which pharmacies
are employing such best practices and improving access. Once enacted, these
provisions will serve as a valuable supplement to existing requirements
under the Americans with Disabilities Act and other federal and state laws
imposing obligations on pharmacies to ensure effective communication and
barrier removal for people with disabilities. 

While the House's treatment of this legislation is less certain, observers
seem to think that action on the Senate bill or on the House's companion
legislation this year has an excellent chance in spite of the contentious
political environment. While the House version does not yet include the drug
label accessibility language, the Chair of the House committee with
jurisdiction over the bill, Rep. Fred Upton (R-MI), affirmed at a recent
hearing on the measure that he is committed to working on inclusion of the
drug label language during the conference process, meaning that if the House
acts on its own bill, House Republican leadership seem willing to advocate
for drug label access language as the House and Senate work to resolve their
differences. 

Stay tuned to AFB-DC for updates on next steps for advocates to take in the
House as this important work moves forward. Special thanks to the many
advocates and organizations who took time, as previously invited via AFB-DC,
to thank key Senate leadership for championing accessible prescription
labeling. 

You can unsubscribe at any time. To remove your name from this mailing list,
or to find out what other newsletters are available from AFB, visit
http://www.afb.org/myAFBNewsletter2.asp.

-------------- next part --------------
A non-text attachment was scrubbed...
Name: ~WRD000.jpg
Type: image/jpeg
Size: 823 bytes
Desc: not available
URL: <http://nfbnet.org/pipermail/nfbmo_nfbnet.org/attachments/20120525/d3c8913e/attachment.jpg>